ETF Objective

The Fund seeks returns linked to the performance of the STOXX Europe 50 USD Index. It aims to provide a quarterly compounded 2x leveraged exposure to the Index. As a result, investors will benefit from two times any positive performance of the Index, and will be exposed to two times any negative performance of the Index.

Stock Chart

as of 4:10 PM ET 09/17/2021

Performance

  • 1 Week
  • -3.15%
  • 1 Month
  • -6.31%
  • 3 Months
  • -4.91%
  • 1 Yr Return
  • +39.35%
  • 5 Yr Return
  • n/a

Sector Breakdown



No Sector Breakdown Information

Geographic Exposure



No Geographic Exposure Data For Symbol

Top 10 Holdings



No Top 10 Holdings Information

ETF Overview

Sponsor Credit Suisse
iNav Ticker DKB7
Inception Date 05/10/2018
Name Crdt Suis FI Enh Eur 50
CUSIP 22539U107
Prospectus Date 06/30/2017

ETF Characteristics

Market Capitalization n/a
Total Net Assets 17.90
Management Fee n/a
Administration Fee n/a
Asset Class Equity
Sub Asset Class Equity Leverage Funds
Number Of Holdings n/a
Expense Ratio n/a
Dividend n/a
Dividend Frequency Annually

Recent Articles from TheStreet

9/11 Lead

Cramer’s Recollections of 9/11

A beautiful day in New York City, Then the Unimaginable

Hong Kong Stocks Slump On Tech Sector Worries As US Official Signals Flaws In China Trade Deal

Intraday Reversals Signal Struggles for Market

But James "Rev Shark" Deporre says the trading action is both normal, and appropriate for September, and he's been adding some names to his portfolio.

stocks market index sh

Cramer's Mad Money Recap: FedEx, Costco, Nike

Jim Cramer says this is a rough season for stock, and investors need to take defensive action.

anxiety grocery mask sh

Jensen: Economy Has a Bearish Outlook

Real Money's Bret Jensen says a slower-than-expected pandemic recovery is a warning for the stock market.

Pfizer vaccine Lead

FDA Panel Recommends Covid Booster Shots for 65, Older and Those at High Risk

Food and Drug Administration's advisory panel on Friday voted to recommend Covid-19 booster shots of the Pfizer vaccine for a limited section of the population.

Ford Lead

Stock Market Today With Jim Cramer: How to Trade Ford

Jim Cramer discusses Ford and the impact of the impending tax policy changes on the stock market.

Jim Cramer: Stay Long Thermo Fisher, Sell FEI

Thermo Fisher Climbs on Strong 2022 Guidance

Thermo Fisher expects revenue to increase 12% year over year next year to $40.3 billion.